Skip to content
Home/ Right Price: A Value-Based Prescription for Drug Costs
Right Price: A Value-Based Prescription for Drug Costs

Right Price: A Value-Based Prescription for Drug Costs

No customer reviews yet ISBN 9780197512876 Oxford University Press

The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only intensify.

The Right Price sheds light on the controversial topic of drug pricing by providing an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic. This volume describes how researchers and policy makers have pursued drug valuation efforts in the past, and lays out a series of recommendations, based on years of shared author experience serving on national drug policy platforms, for how to further improve pharmaceutical value assessment in the United States.

With unique industry insights and clear narrative, The Right Price unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.

About the author

Product details

BrandOxford University Press
Pub dateMay 20, 2021
ISBN-100197512879
ISBN-139780197512876
LanguageEnglish
Dimensions6.19 × 0.65 × 9.25 in
Weight1 lb
Last updated 2026-03-07 13:58
$74.92
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Insurance - Health
See all
Key Issues in Analyzing Major Health Insurance Proposals (2008)
<p><b>NOTE: NO FURTHER DISCOUNT FOR THIS PRINT PRODUCT--OVERSTOCK SALE -- Significantly reduced list price </b><br /><br /> Describes some of the key assumptions used in estimating the effects of proposals to modify the U.S. health insurance system.<br /><br /> Concerns about the number of people who lack health insurance and about the high and rising costs of health insurance and health care have led to proposals that would substantially modify the health insurance system in this country. Because the Medicare program already provides nearly universal coverage to the elderly, those proposals generally focus on options for providing coverage to and reducing costs for the nonelderly population. Because most nonelderly people obtain their insurance coverage through an employer, proposals could affect that coverage in some way. They could, for example, provide new federal subsidies to pay some portion of health insurance premiums&#x3b; impose mandates for individuals to purchase coverage or for employers to offer it&#x3b; encourage alternatives to employment-based insurance or provide strong incentives to purchase coverage individually&#x3b; or create new federally administered options for obtaining health insurance (including a single-payer system in which all citizens or residents would be offered coverage under Medicare).<br /><br /> This report describes some of the key assumptions that the Congressional Budget Office (CBO) would use in estimating the effects of key elements of such proposals on federal costs, insurance coverage, and other outcomes&#x3b; the evidence on which those assumptions are based&#x3b; and--if the evidence points to a range of possible effects rather than a precise prediction-- the factors that would influence where a proposal falls within those ranges. In doing so, it also reviews many of the major issues that arise in designing such proposals. This document does not provide a comprehensive analysis of any specific proposal&#x3b; rather, it identifies and discusses many of the critical factors that would affect estimates of various proposals. In accordance with CBO's mandate to provide objective and impartial analysis, the report makes no recommendations.<br /><br /><b><i>Key Issues in Analyzing Major Health Insurance Proposals </i></b>contains information that would be useful for those who are uninsured and looking for healthcare or those who need help selecting an insurance plan.<br /><br /> Related products: <br /> Other products produced by the <b>U.S. Congressional Budget Office (CBO)</b> can be found here: https: //bookstore.gpo.gov/agency/237<br /><br /><b>The Budget and Economic Outlook: 2016 to 2026</b> can be found here: https: //bookstore.gpo.gov/products/sku/052-070-07697-6?ctid=237</p><b>Reducing the Deficit: Spending and Revenue Options</b> is available here: https: //bookstore.gpo.gov/products/sku/052-070-07612-7?ctid=237<p><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /> https: //bookstore.gpo.gov/agency/237</p>
$36.69